Epidemiology of diseases caused by Streptococcus pyogenes in Serbia during a nine-year period (1991-1999)

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 155-159

  Ranin, Lazar ^a   Opavski, Nataša ^a   Djukić, Slobodanka ^a   Mijač, Vera ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Epidemiology; Erythromycin; Penicillin; Resistance; Streptococcus pyogenes

Indexed keywords

ANTIBIOTIC AGENT; ANTISTREPTOLYSIN; BACITRACIN; ERYTHROMYCIN; M PROTEIN; MACROLIDE; PENICILLIN G; STREPTOCOCCUS ANTIGEN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DISEASE CARRIER; HUMAN; INCIDENCE; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RHEUMATIC FEVER; SCARLET FEVER; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; STREPTOLYSIN TITER; TONSILLITIS; YUGOSLAVIA;

EID: 3442902223     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Efstratiou A. Group A streptococci in 1990s. J Antimicrob Chemother 2000; 45 Topic T1:3-12.
2. www.cdc.gov, accessed in November 2002.
3. www.phls.co.uk, accessed in November 2002.
4. Olivier C. Rheumatic fever - is it still a problem? J Antimicrob Chemother 2000; 45 Topic T1:13-21.
5. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. Circulation 1985; 72: 1155-62.
6. Massell BF, Chute CG, Walker AM, Kurland GS. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988; 318: 280-6.
7. Kaplan EL, Johnson DB. Unexplained reduced microbiological efficacy of the intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 2001; 108: 1180-8.
8. Michel MF, van Leenwen WB. Degree and stability of tolerance to penicillin in Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis 1989; 8: 225-32.
9. Arvand M, Hoeck M, Hahn H, Wagner J. Antimicrobial resistance in Streptococcus pyogenes in Berlin. J Antimicrob Chemother 2000; 46: 621-3.
10. Hsueh P-R, Chen H-M, Huang A-H, Wu J-J. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother 1995; 39: 2239-42.
11. York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco bay area of Northern California. J Clin Microbiol 1999; 37: 1727-31.
12. Bingen E, Fitoussi F, Doit C, Cohen R, Tanna A, George R, et al. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother 2000; 44: 1453-7.
13. Baquero F, Garcia-Rodriguez JA, de Lomas JG, Aguilar L. and Spanish Surveillance Group for Respiratory pathogens. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob Agents Chemother 1999; 43: 178-80.
14. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne. Pa.
15. Kaplan EL. Recent evaluation of antimicrobial resistance in β-hemolytic streptococci. Clin Infect Dis 1997; 24 (Suppl 1): S89-S92.
16. Horn DL, Zabriskie JB, Austrian R, Cleary PP, Ferretti JJ, Fischetti VA, et al. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 1998; 26: 1341-5.
17. Sela S, Barzilai A. Why do we fail with penicillin in the treatment of group A streptococcus infections? Ann Med 1999; 31: 303-7.
18. Granizo JJ, Aguilar L, Casal J, Dal-Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 2000; 46: 959-64.